Nothing Special   »   [go: up one dir, main page]

Choi et al., 2018 - Google Patents

Tonicity-responsive enhancer-binding protein mediates hyperglycemia-induced inflammation and vascular and renal injury

Choi et al., 2018

View HTML
Document ID
11351072538507189374
Author
Choi S
Lim S
Salimi S
Yoo E
Lee-Kwon W
Lee H
Lee J
Mitchell B
Sanada S
Parsa A
Kwon H
Publication year
Publication venue
Journal of the American Society of Nephrology

External Links

Snippet

Diabetic nephropathy (DN) has become the single leading cause of ESRD in developed nations. Bearing in mind the paucity of effective treatment for DN and progressive CKD, novel targets for treatment are sorely needed. We previously reported that increased activity …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Choi et al. Tonicity-responsive enhancer-binding protein mediates hyperglycemia-induced inflammation and vascular and renal injury
Jiao et al. ADAR1 averts fatal type I interferon induction by ZBP1
Aguayo-Mazzucato et al. Acceleration of β cell aging determines diabetes and senolysis improves disease outcomes
Mak et al. HBV RNA profiles in patients with chronic hepatitis B under different disease phases and antiviral therapy
Caiado et al. Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling
Amici et al. CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions
Childs et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis
Navon Elkan et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy
Heraud-Farlow et al. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis
Zhang et al. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration
Sarkar et al. Expression and regulation of chemokines in murine and human type 1 diabetes
Chellapandian et al. Treatment of E pstein B arr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens
Harusato et al. BTB and CNC homolog 1 (Bach1) deficiency ameliorates TNBS colitis in mice: role of M2 macrophages and heme oxygenase-1
Carlsson et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia
Li et al. The hepatocyte-specific HNF4α/miR-122 pathway contributes to iron overload–mediated hepatic inflammation
Pinheiro et al. LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome
Wang et al. Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy
Clark et al. Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy
Huang et al. Endothelial FoxM1 reactivates aging-impaired endothelial regeneration for vascular repair and resolution of inflammatory lung injury
Lei et al. NF-κB activation accounts for the cytoprotective effects of PERK activation on oligodendrocytes during EAE
Taylor et al. CD4 and CD8 T cell memory interactions alter innate immunity and organ injury in the CLP sepsis model
Althaus et al. MYH9 related platelet disorders–often unknown and misdiagnosed
Moreau et al. Review of defective NADPH oxidase activity and myeloperoxidase release in neutrophils from patients with cirrhosis
Al-Azab et al. Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus
Friebus-Kardash et al. Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis